Chemoinformaics analysis of HEXADECYL 2,2,3,3,3-PENTAFLUOROPROPANOATE
| Molecular Weight | 388.461 | nRot | 16 |
| Heavy Atom Molecular Weight | 355.197 | nRig | 1 |
| Exact Molecular Weight | 388.24 | nRing | 0 |
| Solubility: LogS | -2.142 | nHRing | 0 |
| Solubility: LogP | 2.346 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 58.1232 |
| nHD | 0 | BPOL | 41.2748 |
| QED | 0.542 |
| Synth | 1.764 |
| Natural Product Likeliness | 0.016 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.032 |
| Pgp-sub | 0.006 |
| HIA | 0.002 |
| CACO-2 | -4.238 |
| MDCK | 0.0000339 |
| BBB | 0.984 |
| PPB | 0.637323 |
| VDSS | 0.602 |
| FU | 0.50202 |
| CYP1A2-inh | 0.962 |
| CYP1A2-sub | 0.627 |
| CYP2c19-inh | 0.521 |
| CYP2c19-sub | 0.73 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.695 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.282 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.216 |
| CL | 12.104 |
| T12 | 0.834 |
| hERG | 0.048 |
| Ames | 0.01 |
| ROA | 0.05 |
| SkinSen | 0.611 |
| Carcinogencity | 0.157 |
| EI | 0.988 |
| Respiratory | 0.081 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.707457 |